| | CSNK1E, TPTEP2-CSNK1E (R178C) | Single nucleotide variant (missense variant) | Seizure +11 more | |
| | | Single nucleotide variant (splice donor variant) | Decreased response to growth hormone stimulation test | |
| | | Single nucleotide variant (nonsense) | not provided | |
| | GH-LCR, GH1 (Q110E +2 more) | Single nucleotide variant (missense variant) | Decreased response to growth hormone stimulation test | |
| | GH-LCR, GH1 (Q102R +2 more) | Single nucleotide variant (missense variant) | not specified +1 more | |
| | GH-LCR, GH1 (F118L +2 more) | Single nucleotide variant (missense variant) | Decreased response to growth hormone stimulation test | |
| | | Single nucleotide variant (synonymous variant) | Decreased response to growth hormone stimulation test +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (5 prime UTR variant) | not provided +1 more | |
| | | Single nucleotide variant (5 prime UTR variant) | Decreased response to growth hormone stimulation test | |
| | | Single nucleotide variant (5 prime UTR variant) | not provided +1 more | |
| | GH-LCR, GH1 (R113G +2 more) | Single nucleotide variant (missense variant) | Decreased response to growth hormone stimulation test | |
| | | Single nucleotide variant (synonymous variant) | Decreased response to growth hormone stimulation test +1 more | GConflicting classifications of pathogenicity |
| | GH-LCR, GH1 (G142D +2 more) | Single nucleotide variant (missense variant) | Decreased response to growth hormone stimulation test | |
| | GH-LCR, GH1 (D139H +2 more) | Single nucleotide variant (missense variant) | Decreased response to growth hormone stimulation test +1 more | |
| | GH-LCR, GH1 (G172R +2 more) | Single nucleotide variant (missense variant) | Decreased response to growth hormone stimulation test | |
| | | Single nucleotide variant (synonymous variant) | Decreased response to growth hormone stimulation test | |
| | | Single nucleotide variant (missense variant) | not provided +1 more | |
| | | Single nucleotide variant (synonymous variant) | Decreased response to growth hormone stimulation test | |
| | | Single nucleotide variant (missense variant) | Decreased response to growth hormone stimulation test | |
| | | Single nucleotide variant (missense variant) | not provided +2 more | |
| | | Single nucleotide variant (synonymous variant) | Decreased response to growth hormone stimulation test | |
| | | Single nucleotide variant (missense variant) | Decreased response to growth hormone stimulation test | |
| | | Single nucleotide variant (intron variant) | not provided +1 more | GConflicting classifications of pathogenicity |
| | GH-LCR, GH1 (E67D +1 more) | Single nucleotide variant (missense variant +1 more) | Isolated growth hormone deficiency type IB +1 more | |
| | | Single nucleotide variant (intron variant) | Decreased response to growth hormone stimulation test | |
| | | Single nucleotide variant (missense variant +1 more) | Microcephaly +4 more | |
| | | Single nucleotide variant (synonymous variant) | Decreased response to growth hormone stimulation test +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant) | Decreased response to growth hormone stimulation test +1 more | |
| | | Single nucleotide variant (synonymous variant) | not specified +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant) | Decreased response to growth hormone stimulation test +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Isolated growth hormone deficiency, type 5 +1 more | |
| | | Duplication | Ebstein anomaly +2 more | |
| | | Single nucleotide variant (5 prime UTR variant) | not provided +1 more | |
| | | Single nucleotide variant (5 prime UTR variant) | Decreased response to growth hormone stimulation test | |
| | | Single nucleotide variant (5 prime UTR variant) | not provided +5 more | |
| | | Single nucleotide variant (synonymous variant) | not provided +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant) | Decreased response to growth hormone stimulation test | |
| | | Single nucleotide variant (missense variant) | not provided +1 more | |
| | | Single nucleotide variant (missense variant) | Decreased response to growth hormone stimulation test +1 more | |
| | | Single nucleotide variant (intron variant) | Decreased response to growth hormone stimulation test | |
| | | Single nucleotide variant (intron variant) | Decreased response to growth hormone stimulation test | |
| | | Single nucleotide variant (intron variant) | Decreased response to growth hormone stimulation test +1 more | GConflicting classifications of pathogenicity |
| | GH-LCR, GH1 (R160W +2 more) | Single nucleotide variant (missense variant) | Decreased response to growth hormone stimulation test +1 more | |
| | GH-LCR, GH1 (L188P +2 more) | Single nucleotide variant (missense variant) | Decreased response to growth hormone stimulation test | |
| | | Single nucleotide variant (missense variant) | not specified +6 more | |
| | | Single nucleotide variant (missense variant) | not provided +6 more | |
| | | Single nucleotide variant (nonsense) | Inborn genetic diseases +2 more | GPathogenic/Likely pathogenic |
| | | Translocation | Gastrostomy tube feeding in infancy +12 more | |
| | GH-LCR, GH1 (V136I +2 more) | Single nucleotide variant (missense variant) | Decreased response to growth hormone stimulation test +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant) | Decreased response to growth hormone stimulation test +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Autosomal dominant isolated somatotropin deficiency +3 more | |
| | | Single nucleotide variant (synonymous variant) | not specified +2 more | GConflicting classifications of pathogenicity |